Search
Can Fite Biopharma Ltd
CANFAdd to Watchlist
2.330USD
+0.170+7.87%
Close 09-11 16:00（ET）
20.34KMarket Cap
LossP/E TTM
After-hours 18:30 (ET)2.330USD0.000
After-hours 18:30 (ET)TradingKey Chart
Intraday
1m
30m
1h
D
W
M
D
Today
+7.87%
5 Days
+4.48%
1 Month
-31.47%
6 Months
-35.28%
Year to Date
-41.75%
1 Year
-82.35%
Key Figures
2.170Open
2.370High
29.57KVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
338.74%Turnover Ratio
2.160Prev. Close
2.160Low
69.23KTurnover
LossP/E Static
0.00P/B
0.00%Div Yield TTM
-105.48%ROA
10.40052wk High
0.18Volume Ratio
-7.88MNet Profit
8.73KShares
-1791.0240EPS TTM
1.11Beta
-178.24%ROE
3.36052wk Low
9.26%Amplitude
100.00%Gross Margin
20.34KMarket Cap
0.51Reward/Risk
117.22%Risk Rate
More news coming soon, stay tuned...
Can Fite Biopharma Ltd's Score
-0.26vs previous score
Forecast8.00
Financial Health5.51
Technical5.43
Valuation Dimensions8.03
Institutional Confidence3.00
Risk Assessment--
Media Coverage
Coverage Level
Very Low
Very High
Neutral
Analyst Rating
Can Fite Biopharma Ltd Technical Analysis
Technical Indicators
Sell
Summary
Sell
Moving Average
Strong sell
Financial Indicators
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
Earnings
Next reporting date
--
Reporting Period
2025
Earnings / Forecast
--/--
Revenue / Forecast
--/--
Can Fite Biopharma Ltd Profile
SectorPharmaceuticals
Ticker SymbolCANF
Number of employees5
CountryIsrael
Ownership
| Shareholders | Proportion |
|---|---|
| Rhumbline Advisers Ltd. Partnership | 0.98% |
| Citi Investment Research (US) | 0.26% |
| UBS Financial Services, Inc. | 0.10% |
| Abalone Asset Management Ltd. | 0.09% |
| Shareholder Types | Proportion |
|---|---|
| Investment Advisor | 0.94% |
| Research Firm | 0.48% |
| Venture Capital | 0.04% |
| Hedge Fund | 0.03% |
Related Instruments
-0.65%
-0.29%
+0.33%
+0.83%
-0.54%
-0.23%
-1.34%
-0.75%
+0.25%
-2.14%
+0.17%
-0.17%
+0.12%
+0.07%
+0.02%
-1.48%
+0.04%
+0.83%
+5.38%
-0.61%Popular Instruments
52473.000
-80.000 (-0.15%)
28990.100
-378.800 (-1.29%)
7614.200
-42.400 (-0.55%)
14410.000
-46.000 (-0.32%)
62823.000
-1856.000 (-2.87%)
6293.600
-26.200 (-0.41%)
101.043
+2.686 (+2.73%)
332.270
+5.700 (+1.75%)
218.290
-0.070 (-0.03%)
4333.890
-14.160 (-0.33%)
FAQs
What is the current price of Can Fite Biopharma Ltd (CANF)?
The current price of Can Fite Biopharma Ltd (CANF) is 2.33.
What is the symbol of Can Fite Biopharma Ltd?
The ticker symbol of Can Fite Biopharma Ltd is CANF.
What is the 52-week high of Can Fite Biopharma Ltd?
The 52-week high of Can Fite Biopharma Ltd is 10.40.
What is the 52-week low of Can Fite Biopharma Ltd?
The 52-week low of Can Fite Biopharma Ltd is 3.36.
What is the market capitalization of Can Fite Biopharma Ltd?
The market capitalization of Can Fite Biopharma Ltd is 20.34K.
What is the Earnings Per Share (EPS TTM) of Can Fite Biopharma Ltd (CANF)?
The Earnings Per Share (EPS TTM) of Can Fite Biopharma Ltd (CANF) is -1791.02.